Estradiol valerate/testosterone enanthate
combination drug
Estradiol valerate/testosterone enanthate (EV/TE), sold under the brand names Primodian Depot and Ditate among others, is an injectable combination medication of estradiol valerate (EV), an estrogen, and testosterone enanthate (TE), an androgen/anabolic steroid, which is used in menopausal hormone therapy for women. The medication is also used to suppress lactation in postpartum women (brand name Deladumone).
Ditate was provided in the form of multi-use 10 mL vials containing 4 mg/mL EV and 90 mg/mL TE in an oil solution and was administered by intramuscular injection at regular intervals. Conversely, another preparation, Ditate-DS, was provided in the form of single-use 2 mL vials containing 8 mg/mL EV and 180 mg/mL TE in an oil solution, and was administered as a single intramuscular injection. Another product, Primodian
Depot, was provided in the form of 1 mL ampoules containing 4 mg/mL EV (3.0 mg/mL free estradiol) and 90.3 mg/mL TE (65 mg/mL free testosterone) in an oil solution, and was administered by intramuscular injection once every 4 to 6 weeks. The elimination half-life of EV in oil by intramuscular injection is approximately 4 or 5 days. Similarly, the elimination half-life of TE in oil by intramuscular injection is approximately 4 or 5 days. EV/TE reportedly has a duration of about 21 days.
Deladumone OB was a double-dosage formulation of Deladumone, which was intended to provide the same dosage with a smaller injection volume.
Primodian Depot was introduced for medical use by 1955.
The public source identifies “Estradiol valerate/testosterone enanthate” as combination drug. This brief keeps that definition visible, then builds a research path around Estradiol, valerate and testosterone.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Estradiol valerate/testosterone enanthate”, the useful work is to connect “combination drug” to the records capable of establishing context and consequence.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Dec 23, 2025. The linked authority identifier is Q64363012. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1955.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Estradiol valerate/testosterone enanthate”, its source revision and the description used here.
- Expand the search: follow Estradiol valerate/testosterone enanthate primary sources, Estradiol valerate/testosterone enanthate archive and Estradiol research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Estradiol valerate/testosterone enanthate”?
- What terminology or title could unlock a more precise catalogue search?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Estradiol valerate/testosterone enanthate” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.